Dana-Farber Cancer Institute - Hematology/Oncology
Dana-Farber Cancer Institute - Hematology/Oncology
Boston, Massachusetts, United States2 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of T-Cell Receptor Engineered Donor T Cells in Subjects Undergoing Allogeneic Peripheral Blood Stem Cell Transplantation | acute myeloid leukemia, myelodysplastic syndrome | Active, not recruiting | Phase 3 | 2026-10-05 | NCT07702578 | |
| A Study of T-Cell Receptor Engineered Donor T Cells in Subjects Undergoing Allogeneic Peripheral Blood Stem Cell Transplantation (ALLOHA) | acute myeloid leukemia, myelodysplastic syndrome | Active, not recruiting | Phase 1 | 2026-10-05 | NCT05473910 |